🔥🐔 BizChicken 🐔🔥
Companies Similar to Tevogen Bio Holdings Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Biogen Inc.
TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS
Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.
About | About | Vision/Values | Leadership | Foundation | Contact | Careers | Careers | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: BIIB
Recent Price: $150.19
Industry: Drug Manufacturers - General
CEO: Mr. Christopher A. Viehbacher
Sector: Healthcare
Employees: 7570
Address: 225 Binney Street, Cambridge, MA 02142
Phone: 617 679 2000
Leadership
- Christopher A. Viehbacher, President and Chief Executive Officer
- Susan H. Alexander, Chief Legal Officer
- Ginger Gregory, Ph.D., Chief Human Resources Officer
- Jane Grogan, Ph.D., Head of Research
- Rachid Izzar, Head of Global Product Strategy & Commercialization
- Adam Keeney, Head of Corporate Development
- Michael McDonnell, Chief Financial Officer
- Nicole Murphy, Head of Pharmaceutical Operations and Technology
- Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
- Alisha Alaimo, President, Head of North America
- Stephen Amato, Head of Investor Relations
- Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
- Fraser Hall, President, Head of Intercontinental Region
- Wolfram Schmidt, President, Head of Europe
- Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
- Caroline Dorsa, Chair of the Board
- Maria C. Freire, Ph.D., Director
- William A. Hawkins, Director
- Susan Langer, Director
- Jesus B. Mantas, Director
- Lloyd B. Minor, M.D., Director
- Monish Patolawala, Director
- Eric K. Rowinsky, M.D., Director
- Stephen A. Sherwin, M.D., Director
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Precigen, Inc.
gene and cellular therapies
Precigen, Inc. is focused on discovering and developing advanced gene and cellular therapies, disease-modifying therapeutics, and genetic engineering technologies for regenerative medicine and other applications.
About | Contact | Careers | Careers | Careers | About | About | Benefits | Careers | About | About | About | Careers | Careers | About
Symbol: PGEN
Recent Price: $0.93
Industry: Biotechnology
CEO: Dr. Helen Sabzevari MPH, Ph.D.
Sector: Healthcare
Employees: 202
Address: 20374 Seneca Meadows Parkway, Germantown, MD 20876
Phone: 301 556 9900
Last updated: 2024-12-31
Novavax, Inc.
NVX-Co V2373
Novavax, Inc. is a biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Their vaccine candidates include NVX-Co V2373, Nano Flu, and Res Vax. The company operates collaboratively with Takeda Pharmaceutical Company Limited on COVID-19 vaccine development.
Contact | Careers | Careers | Careers | Careers | About | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About | About | About
Symbol: NVAX
Recent Price: $7.93
Industry: Biotechnology
CEO: Mr. John Charles Jacobs M.B.A.
Sector: Healthcare
Employees: 1543
Address: 21 Firstfield Road, Gaithersburg, MD 20878
Phone: 240 268 2000
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
bluebird bio, Inc.
betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel
bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.
About | Leadership | DEI | About | About | About | Contact | Careers | About | About | About | About
Symbol: BLUE
Recent Price: $7.86
Industry: Biotechnology
CEO: Mr. Andrew Obenshain
Sector: Healthcare
Employees: 375
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Leadership
- Sarah Alspach, Senior Vice President, External Affairs
- Rich Colvin, MD, PhD, Chief Medical Officer
- Kasra Kasraian, Senior Vice President, Technical Development and Operations
- Tom Klima, Chief Commercial & Operating Officer
- Andrew Obenshain, Chief Executive Officer
- Scott Shoemaker, Senior Vice President, Quality
- James Sterling, Chief Financial Officer
- Joe Vittiglio, Chief Business and Legal Officer
- Andrea Walton, Chief People Officer
- Leslie Wilder, Vice President, Head of Regulatory Science
- Mark Vachon, Chairman; Formerly of GE
- John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
- Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
- Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
- Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
- Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
- Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
- Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Organovo Holdings, Inc.
Novo Gen Bioprinters
Organovo Holdings, Inc. is a biotechnology company that develops 3D tissues to model human diseases, utilizing proprietary bioprinting technologies such as Novo Gen Bioprinters for fabricating living tissues.
About | About | About | About | Leadership | Directors | Contact | Contact | Contact | Careers
Symbol: ONVO
Recent Price: $0.36
Industry: Biotechnology
CEO: Mr. Keith E. Murphy
Sector: Healthcare
Employees: 20
Address: 11555 Sorrento Valley Road, Solana Beach, CA 92121
Phone: 858 224 1000
Leadership
- Keith Murphy, Executive Chairman, CEO
- Thomas P. Hess, Chief Financial Officer
- Curtis Tyree, Ph.D., Senior Vice President, Strategy and Business Development
- Adam K. Stern, CEO
- Alison Milhous, Vice President, Accounting
- David Gobel, CEO
- Doug Cohen, President and Chief Executive Officer
- Vaidehi Joshi, Director of Discovery Biology
Last updated: 2024-12-31
Sonnet BioTherapeutics Holdings, Inc.
SON-1010, SON-080
Sonnet Bio Therapeutics Holdings, Inc. is a clinical stage oncology-focused biotechnology company developing biologic medicines using its human albumin binding technology. The company is based in Princeton, New Jersey, and has lead candidates such as SON-1010 for non-small cell lung cancer, and SON-080 for neuropathies.
Symbol: SONN
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Pankaj Mohan Ph.D.
Sector: Healthcare
Employees: 12
Address: 100 Overlook Center, Princeton, NJ 08540
Phone: 609-375-2227
Leadership
- Pankaj Mohan, Ph.D., Founder, CEO & Chairman
- Jay Cross, Chief Financial Officer
- John K. Cini, Ph.D., Chief Scientific Officer & Co-Founder
- Susan Dexter, Chief Technical Officer
- Richard Kenney, M.D., Chief Medical Officer
- Albert Dyrness, Board Member
- Nailesh Bhatt, Chief Executive Officer & Board Member
- Raghu Rao, Board Member
- Donald Griffith, Financial Controller
- Lori McNeill, Board Member
Last updated: 2024-12-31
2seventy bio, Inc.
idecabtagene vicleucel
2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.
Symbol: TSVT
Recent Price: $2.89
Industry: Biotechnology
CEO: Mr. William D. Baird III, M.B.A.
Sector: Healthcare
Employees: 274
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Last updated: 2024-12-31
Tevogen Bio Holdings Inc.
TVGN 489
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company developing off-the-shelf precision T cell therapeutics focusing on virology, oncology, and neurology, with a key focus on COVID-19 and long COVID treatments.
About | News | News | News | About | News | News | Contact | About | About | Careers | About | About | About | About | About | About | About
Symbol: TVGN
Recent Price: $1.05
Industry: Biotechnology
CEO: Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Sector: Healthcare
Employees: 17
Address: 15 Independence Blvd, Warren, NJ 07059
Phone: 877 838 6436
Last updated: 2024-12-31
Vir Biotechnology, Inc.
Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111
Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.
Vision/Values | About | Leadership | About | Contact | Contact | Careers | Jobs | About | About
Symbol: VIR
Recent Price: $7.33
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Sector: Healthcare
Employees: 587
Address: 499 Illinois Street, San Francisco, CA 94158
Phone: 415 906 4324
Leadership
- Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
- Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
- Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
- Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
- Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
- Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
- Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
- Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
- Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
- Arran Attridge, Senior Vice President Corporate Communications
- Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
- Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow
Last updated: 2024-12-31
Viking Therapeutics, Inc.
VK2809
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for metabolic and endocrine disorders, with lead drug candidate VK2809 in Phase IIb trials for non-alcoholic steatohepatitis.
Symbol: VKTX
Recent Price: $39.77
Industry: Biotechnology
CEO: Dr. Brian Lian Ph.D.
Sector: Healthcare
Employees: 30
Address: 9920 Pacific Heights Boulevard, San Diego, CA 92121
Phone: 858 704 4660
Leadership
- Lawson Macartney, DVM, Ph.D., Chairman
- Matthew W. Foehr, Chief Executive Officer
- Kathy Rouan, Ph.D.,
- Charles A. Rowland Jr.,
- Matthew Singleton,
- Brian Lian, Ph.D.,
Last updated: 2024-12-31
Viridian Therapeutics, Inc.
VRDN-001, VRDN-002, VRDN-003
Viridian Therapeutics, Inc. is a biotechnology company focused on developing treatments for patients suffering from serious diseases, including thyroid eye disease.
Symbol: VRDN
Recent Price: $19.54
Industry: Biotechnology
CEO: Mr. Stephen F. Mahoney J.D., MBA
Sector: Healthcare
Employees: 94
Address: 221 Crescent Street, Waltham, MA 02453
Phone: 617 272 4600
Last updated: 2024-12-31
vTv Therapeutics Inc.
TTP399
v Tv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing orally administered treatments for diabetes and other diseases. Key products include TTP399 for type 1 diabetes and HPP737 for inflammatory diseases.
Symbol: VTVT
Recent Price: $13.97
Industry: Biotechnology
CEO: Mr. Paul J. Sekhri M.Sc.
Sector: Healthcare
Employees: 16
Address: 3980 Premier Drive, High Point, NC 27265
Phone: 336 841 0300
Last updated: 2024-12-31
Ginkgo Bioworks Holdings, Inc.
platform for cell programming
Ginkgo Bioworks Holdings, Inc. develops a platform used to program cells for biological production of products such as therapeutics, food ingredients, and chemicals. It serves markets in specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.
About | About | Contact | Contact | About | About | About | About | Vision/Values | About | About | About | Culture | About | Careers | About | About | About
Symbol: DNA
Recent Price: $9.44
Industry: Biotechnology
CEO: Dr. Jason Kelly
Sector: Healthcare
Employees: 1218
Address: 27 Drydock Avenue, Boston, MA 02210
Phone: 877 422 5362
Last updated: 2024-12-31
Theriva Biologics, Inc.
SYN-004, SYN-020, VCN-01
Theriva Biologics Inc. is a clinical-stage company developing therapeutics to address diseases with high unmet needs, including SYN-004 for preventing microbiome damage and SYN-020 for treating GI and systemic diseases.
Symbol: TOVX
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Steven A. Shallcross CPA
Sector: Healthcare
Employees: 22
Address: 9605 Medical Center Drive, Rockville, MD 20850
Phone: 301 417 4364
Last updated: 2024-12-31
IN8bio, Inc.
INB-200, INB-100, INB-400, INB-300
IN8bio, Inc. is a clinical-stage biotechnology company focused on gamma-delta T cell therapies for cancer treatment, with lead products in clinical trials and preclinical development.
Symbol: INAB
Recent Price: $0.27
Industry: Biotechnology
CEO: Mr. Tai-Wei Ho
Sector: Healthcare
Employees: 39
Address: 350 5th Avenue, New York, NY 10118
Phone: 646 600 6438
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31